WKÖ Garten
-
Silent Auditorium | Sprache: Englisch
Innovation Talk: AION Labs - Proofing a New Norm for Biotech Venture Studios
This session promises to offer a glimpse into the future of drug development, where ideas are truly nurtured with funding, infrastructure, and expert guidance. Mati Gill CEO of AION Labs will delve into how the idea behind this first-of-its-kind venture studio came about, why the location of the studio matters, and how this new environment empowers start-ups to grow stronger and faster through quality data, real-time benchmarking, and access to exceptional talent. Don’t forget to stay for the open discussion!